These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3144210)

  • 1. Minimal inhibitory concentrations of isoniazid, rifampin, ethambutol, and streptomycin against Mycobacterium tuberculosis strains isolated before treatment of patients in Taiwan.
    Suo J; Chang CE; Lin TP; Heifets LB
    Am Rev Respir Dis; 1988 Oct; 138(4):999-1001. PubMed ID: 3144210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal inhibitory concentrations of rifabutin, ciprofloxacin, and ofloxacin against Mycobacterium tuberculosis isolated before treatment of patients in Taiwan.
    Chen CH; Shih JF; Lindholm-Levy PJ; Heifets LB
    Am Rev Respir Dis; 1989 Oct; 140(4):987-9. PubMed ID: 2552883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line drugs.
    Coban AY; Cihan CC; Bilgin K; Uzun M; Akgunes A; Cetinkaya E; Durupinar B
    Int J Tuberc Lung Dis; 2006 Apr; 10(4):450-3. PubMed ID: 16602412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998.
    Laszlo A; Rahman M; Espinal M; Raviglione M;
    Int J Tuberc Lung Dis; 2002 Sep; 6(9):748-56. PubMed ID: 12234129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifabutine: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis.
    Heifets LB; Lindholm-Levy PJ; Iseman MD
    Am Rev Respir Dis; 1988 Mar; 137(3):719-21. PubMed ID: 2830815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis.
    Schön T; Juréen P; Giske CG; Chryssanthou E; Sturegård E; Werngren J; Kahlmeter G; Hoffner SE; Angeby KA
    J Antimicrob Chemother; 2009 Oct; 64(4):786-93. PubMed ID: 19633001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiometric and conventional drug susceptibility testing of Mycobacterium tuberculosis.
    Hoel T; Eng J
    APMIS; 1991 Nov; 99(11):977-80. PubMed ID: 1958354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tuberculosis drug susceptibility testing of Mycobacterium bovis BCG Tokyo strain.
    Shishido Y; Mitarai S; Otomo K; Seki M; Sato A; Yano I; Koyama A; Hattori T
    Int J Tuberc Lung Dis; 2007 Dec; 11(12):1334-8. PubMed ID: 18034955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Resistance rates to major anti-tuberculosis drugs in Mycobacterium tuberculosis strains isolated from seven different regions of Turkey in 2003-2006 period].
    Uçar E; Kiliç A; Ceyhan I; Yilmaz S; Kiliç S; Tarhan G; Simşek H; Güllü U; Başustaoğlu AC
    Mikrobiyol Bul; 2010 Jan; 44(1):11-9. PubMed ID: 20455394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sensitivity tests of mycobacteria to INH, SM, EMB and RMP in a semi-liquid serum-sauton-agar (author's transl)].
    Neubert R
    Z Erkr Atmungsorgane; 1976; 144(1):63-8. PubMed ID: 823718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of a reverse dot blot hybridization assay for simultaneous detection of the resistance of four anti-tuberculosis drugs in Mycobacterium tuberculosis isolated from China.
    Wan L; Guo Q; Wei JH; Liu HC; Li MC; Jiang Y; Zhao LL; Zhao XQ; Liu ZG; Wan KL; Li GL; Guan CX
    Infect Dis Poverty; 2020 Apr; 9(1):38. PubMed ID: 32299480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood agar validation for susceptibility testing of isoniazid, rifampicin, ethambutol, and streptomycin to Mycobacterium tuberculosis isolates.
    Coban AY
    PLoS One; 2013; 8(2):e55370. PubMed ID: 23405140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987.
    Jalleh RD; Kuppusamy I; Soshila R; Aziah AM; Faridza MY
    Med J Malaysia; 1993 Jun; 48(2):113-6. PubMed ID: 8350784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro synergistic interactions of oleanolic acid in combination with isoniazid, rifampicin or ethambutol against Mycobacterium tuberculosis.
    Ge F; Zeng F; Liu S; Guo N; Ye H; Song Y; Fan J; Wu X; Wang X; Deng X; Jin Q; Yu L
    J Med Microbiol; 2010 May; 59(Pt 5):567-572. PubMed ID: 20075118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems.
    Huang TS; Tu HZ; Lee SS; Huang WK; Liu YC
    Ann Clin Lab Sci; 2002; 32(2):142-7. PubMed ID: 12017195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs.
    Heifets L
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1131-6. PubMed ID: 2461162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
    Dickinson JM; Aber VR; Mitchison DA
    Am Rev Respir Dis; 1977 Oct; 116(4):627-35. PubMed ID: 411404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the ESP culture system II for testing susceptibilities of Mycobacterium tuberculosis isolates to four primary antituberculous drugs.
    Bergmann JS; Woods GL
    J Clin Microbiol; 1998 Oct; 36(10):2940-3. PubMed ID: 9738047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The resistance rates of Mycobacterium tuberculosis strains to antituberculosis drugs: evaluation of two years' data in Aegean region, Turkey].
    Güneri S; Unsal I; Oztop A; Erkut M; Avkan Oğuz V; Ozgü A; Cakmak R
    Mikrobiyol Bul; 2004 Jul; 38(3):203-12. PubMed ID: 15490839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the E-test and proportion methods for susceptibility testing of Mycobacterium tuberculosis.
    Sanic A; Gunaydin M; Coban AY; Tokac ; Cetin M
    J Chemother; 2000 Dec; 12(6):491-4. PubMed ID: 11154031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.